Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients: Comment to “Clinical outcomes of stereotactic body radiation therapy for malignant pleural... von Ceresoli, Giovanni L., Ghirardelli, Paolo, Vavassori, Vittorio

Volltext

Tumour Treating Fields for mesothelioma – Authors' reply von Ceresoli, Giovanni L, Gianoncelli, Letizia, Grosso, Federica

Volltext

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre,... von Ceresoli, Giovanni L, Aerts, Joachim G, Dziadziuszko, Rafal, Ramlau, Rodryg, Cedres, Susana, van Meerbeeck, Jan P, Mencoboni, Manlio, Planchard, David, Chella, Antonio, Crinò, Lucio, Krzakowski, Maciej, Rüssel, Jörn, Maconi, Antonio, Gianoncelli, Letizia, Grosso, Federica

Volltext

A reply to “managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy” von Ceresoli, Giovanni L., Ghirardelli, Paolo, Franceschini, Davide, Scorsetti, Marta, Vavassori, Vittorio

Volltext

Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer von Cappuzzo, Federico, Hirsch, Fred R., Rossi, Elisa, Bartolini, Stefania, Ceresoli, Giovanni L., Bemis, Lynne, Haney, Jerry, Witta, Samir, Danenberg, Kathleen, Domenichini, Irene, Ludovini, Vienna, Magrini, Elisabetta, Gregorc, Vanesa, Doglioni, Claudio, Sidoni, Angelo, Tonato, Maurizio, Franklin, Wilbur A., Crino, Lucio, Bunn, Paul A., Varella-Garcia, Marileila

Volltext

Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma von CERESOLI, Giovanni L, ZUCALI, Paolo A, MARANGOLO, Maurizio, SOTO PARRA, Hector J, SANTORO, Armando, FAVARETTO, Adolfo G, GROSSI, Francesco, BIDOLI, Paolo, DEL CONTE, Guido, CERIBELLI, Anna, BEARZ, Alessandra, MORENGHI, Emanuela, CAVINA, Raffaele

Volltext

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placeb... von Scagliotti, Giorgio V, Gaafar, Rabab, Nowak, Anna K, Nakano, Takashi, van Meerbeeck, Jan, Popat, Sanjay, Vogelzang, Nicholas J, Grosso, Federica, Aboelhassan, Rasha, Jakopovic, Marko, Ceresoli, Giovanni L, Taylor, Paul, Orlandi, Francisco, Fennell, Dean A, Novello, Silvia, Scherpereel, Arnaud, Kuribayashi, Kozo, Cedres, Susana, Sørensen, Jens Benn, Pavlakis, Nick, Reck, Martin, Velema, Derek, von Wangenheim, Ute, Kim, Miyoung, Barrueco, José, Tsao, Anne S

Volltext

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial von Kindler, Hedy L, Novello, Silvia, Bearz, Alessandra, Ceresoli, Giovanni L, Aerts, Joachim G J V, Spicer, James, Taylor, Paul, Nackaerts, Kristiaan, Greystoke, Alastair, Jennens, Ross, Calabrò, Luana, Burgers, Jacobus A, Santoro, Armando, Cedrés, Susana, Serwatowski, Piotr, Ponce, Santiago, Van Meerbeeck, Jan P, Nowak, Anna K, Blumenschein, Jr, George, Siegel, Jonathan M, Kasten, Linda, Köchert, Karl, Walter, Annette O, Childs, Barrett H, Elbi, Cem, Hassan, Raffit, Fennell, Dean A

Volltext

Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma von Ghirardelli, Paolo, Franceschini, Davide, D’Aveni, Alessandro, Dominici, Luca, Ravasio, Andrea, Marzo, Marco, Villa, Elisa, Di Noia, Vincenzo, Scorsetti, Marta, Vavassori, Vittorio, Ceresoli, Giovanni L.

Volltext

Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients von CAPPUZZO, Federico, VARELLA-GARCIA, Marileila, FRANKLIN, Wilbur A, CRINO, Lucid, GAZDAR, Adi F, BUNN, Paul A, HIRSCH, Fred R, SHIGEMATSU, Hisayuki, DOMENICHINI, Irene, BARTOLINI, Stefania, CERESOLI, Giovanni L, ROSSI, Elisa, LUDOVINI, Vienna, GREGORC, Vanesa, TOSCHI, Luca

Volltext

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesotheliom... von GREGORC, Vanesa, ZUCALI, Paolo A, SPREAFICO, Anna, VIGANO, Maria Grazia, FONTANA, Floriana, DE BRAUD, Filippo G, BAJETTA, Emilio, CALIGARIS-CAPPIO, Federico, BRUZZI, Paolo, LAMBIASE, Antonio, BORDIGNON, Claudio, SANTORO, Armando, CERESOLI, Giovanni L, CITTERIO, Giovanni, DE PAS, Tommaso M, ZILEMBO, Nicoletta, DE VINCENZO, Fabio, SIMONELLI, Matteo, ROSSONI, Gilda

Volltext

Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations von Mannarino, Laura, Mirimao, Federica, Panini, Nicolò, Paracchini, Lara, Marchini, Sergio, Beltrame, Luca, Amodeo, Rosy, Grosso, Federica, Libener, Roberta, De Simone, Irene, Ceresoli, Giovanni L., Zucali, Paolo A., Lupi, Monica, D’Incalci, Maurizio

Volltext

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma von Ceresoli, Giovanni L, Zucali, Paolo A, De Vincenzo, Fabio, Gianoncelli, Letizia, Simonelli, Matteo, Lorenzi, Elena, Ripa, Cristina, Giordano, Laura, Santoro, Armando

Volltext

Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer. von Pala, Laura, Sala, Isabella, Pagan, Eleonora, De Pas, Tommaso, Zattarin, Emma, Catania, Chiara, Cocorocchio, Emilia, Rossi, Giovanna, Laszlo, Daniele, Ceresoli, Giovanni, Canzian, Jacopo, Valenzi, Elena, Bagnardi, Vincenzo, Conforti, Fabio

Volltext

Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography With [18F]Fluorodeoxyglucose von CERESOLI, Giovanni L, CHITI, Arturo, ZUCALI, Paolo A, RODARI, Marcello, LUTMAN, Romano F, SALAMINA, Silvia, INCARBONE, Matteo, ALLOISIO, Marco, SANTORO, Armando

Volltext

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin von ANDREA ZUCALI, Paolo, GIOVANNETTI, Elisa, BRUZZONE, Andrea, THUNNISSEN, Erik, TUNESI, Gianni, GIORDANO, Laura, RONCALLI, Massimo, PETERS, Godefridus J, SANTORO, Armando, DESTRO, Annarita, MENCOBONI, Manlio, LUCA CERESOLI, Giovanni, GIANONCELLI, Letizia, LORENZI, Elena, DE VINCENZO, Fabio, SIMONELLI, Matteo, PERRINO, Matteo

Volltext

Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma von Zucali, Paolo A., Ceresoli, Giovanni L., Garassino, Isabella, De Vincenzo, Fabio, Cavina, Raffaele, Campagnoli, Elisabetta, Cappuzzo, Federico, Salamina, Silvia, Soto Parra, Hector J., Santoro, Armando

Volltext

Significance of Neutrophil-to-lymphocyte Ratio in Western Advanced EGFR-mutated Non-small Cell Lung Cancer Receiving a Targeted Therapy von Meriggi, Fausto, Codignola, Claudio, Beretta, Giordano D., Ceresoli, Giovanni L., Caprioli, Alberto, Scartozzi, Mario, Fraccon, Anna P., Prochilo, Tiziana, Ogliosi, Chiara, Zaniboni, Alberto

Volltext

Immune checkpoint inhibitors in mesothelioma: a turning point von Ceresoli, Giovanni Luca, Pasello, Giulia

Volltext

Clinical staging of malignant pleural mesothelioma: current perspectives von Bonomi, Maria, De Filippis, Costantino, Lopci, Egesta, Gianoncelli, Letizia, Rizzardi, Giovanna, Cerchiaro, Eleonora, Bortolotti, Luigi, Zanello, Alessandro, Ceresoli, Giovanni Luca

Volltext